Keloid treatment
AssigneeAde Therapeutics Inc.
InventorsAdebola O.E. Obayan, Sanjeev Singh, Brenda Collen Joyce Yuzdepski
Life of this patent
Estimating the term…
Abstract
Due to a long-standing interest in scar reduction, alanyl-glutamine was tested for ability to treat keloid scars, despite the difficulties associated with delivering compounds above a certain size threshold across the skin barrier to the dermis where new skin is formed. Surprisingly, it was found that a dermal application formulation of alanyl-glutamine was effective in reducing the severity and/or preventing the formation of keloid scars.
Claims8
1-5. (canceled)
A method of treating or preventing a keloid scar comprising topically administering to the keloid scar or a site of potential keloid scar formation an effective amount of a glutamine source.
A pharmaceutical composition for topical administration comprising glutamine and one or more pharmaceutically acceptable carriers.
Dependencies are inferred from the claim text.